Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-01 Sale | 2024-03-05 5:40 pm | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 6,770 | $1.5276 | $10,342 | 317,368 (Direct) | View |
2024-03-04 Sale | 2024-03-05 5:40 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 6,095 | $1.5276 | $9,311 | 929,998 (Direct) | View |
2024-03-04 Sale | 2024-03-05 5:39 pm | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 4,573 | $1.5276 | $6,986 | 323,840 (Direct) | View |
2024-02-05 Sale | 2024-02-06 4:07 pm | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 2,714 | $0.9025 | $2,449 | 129,413 (Direct) | View |
2024-02-05 Sale | 2024-02-06 4:07 pm | bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer | 5,217 | $0.9025 | $4,708 | 44,783 (Direct) | View |
2024-02-05 Sale | 2024-02-06 4:07 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 1,879 | $0.9025 | $1,696 | 286,093 (Direct) | View |
2024-01-05 Sale | 2024-01-09 4:05 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 3,162 | $1.4294 | $4,520 | 287,972 (Direct) | View |
2024-01-05 Sale | 2024-01-09 4:05 pm | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 597 | $1.415 | $845 | 125,138 (Direct) | View |
2023-12-06 Sale | 2023-12-08 4:42 pm | bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer | 4,526 | $4.5155 | $20,437 | 45,474 (Direct) | View |
2023-11-03 Sale | 2023-11-03 4:10 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 807 | $3.1659 | $2,555 | 291,134 (Direct) | View |
2023-11-02 Sale | 2023-11-03 4:10 pm | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 2,343 | $2.9769 | $6,975 | 125,735 (Direct) | View |
2023-09-05 Sale | 2023-09-06 4:30 pm | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 922 | $3.7886 | $3,493 | 132,127 (Direct) | View |
2023-08-10 Sale | 2023-08-10 5:00 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 16,929 | $3.5416 | $59,956 | 291,941 (Direct) | View |
2023-06-02 Sale | 2023-06-06 4:06 pm | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 4,130 | $3.499 | $14,451 | 133,049 (Direct) | View |
2022-10-17 Sale | 2023-03-09 4:06 pm | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 1,004 | $6.4643 | $6,490 | 11,466 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:19 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 3,178 | $7.8043 | $24,802 | 242,690 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:19 pm | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 557 | $7.8043 | $4,347 | 74,231 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:19 pm | bluebird bio Inc. | BLUE | Leschly Nick Director | 4,290 | $7.8043 | $33,480 | 448,848 (Indirect Direct) | View |
2022-11-04 Sale | 2022-11-08 5:46 pm | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 218 | $6.4137 | $1,398 | 74,788 (Direct) | View |
2022-11-04 Sale | 2022-11-08 5:46 pm | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 1,263 | $6.4137 | $8,101 | 245,868 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Option Award | 2024-03-05 5:40 pm | N/A 2034-03-01 | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 199,000 | $0 | 317,368 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 5:40 pm | N/A 2034-03-01 | bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer | 199,000 | $0 | 199,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 5:40 pm | N/A 2034-03-01 | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 650,000 | $0 | 929,998 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 5:39 pm | N/A 2034-03-01 | bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer | 199,000 | $0 | 199,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 5:39 pm | N/A 2034-03-01 | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 199,000 | $0 | 323,840 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:31 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Tita-Reid Najoh Director | 32,390 | $0 | 44,860 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:31 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Agwunobi John O Director | 32,390 | $0 | 48,064 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:31 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Vachon Mark Director | 32,390 | $0 | 46,641 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:31 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Leschly Nick Director | 32,390 | $0 | 481,238 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:30 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Leiderman Elisabeth Director | 32,390 | $0 | 43,856 (Direct) | View |
2023-06-16 Option Award | 2023-06-20 4:30 pm | N/A 2033-06-16 | bluebird bio Inc. | BLUE | Jones-Burton Charlotte Director | 32,390 | $0 | 40,162 (Direct) | View |
2023-04-03 Option Award | 2023-04-05 4:07 pm | N/A 2033-04-03 | bluebird bio Inc. | BLUE | Paulson Richard A. Director | 12,163 | $0 | 12,163 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:43 pm | N/A 2033-03-01 | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 165,000 | $0 | 238,078 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:43 pm | N/A 2033-03-01 | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 405,600 | $0 | 646,870 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 4:43 pm | N/A 2033-03-01 | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 165,000 | $0 | 247,179 (Direct) | View |
2023-02-01 Tax Withholding | 2023-02-03 4:06 pm | N/A N/A | bluebird bio Inc. | BLUE | Klima Thomas J See Remarks | 2,260 | $6.38 | 82,179 (Direct) | View |
2023-02-01 Tax Withholding | 2023-02-03 4:05 pm | N/A N/A | bluebird bio Inc. | BLUE | Colvin Richard A Chief Medical Officer | 1,153 | $6.38 | 73,078 (Direct) | View |
2023-02-01 Tax Withholding | 2023-02-03 4:05 pm | N/A N/A | bluebird bio Inc. | BLUE | Obenshain Andrew President and CEO | 1,420 | $6.38 | 241,270 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 4:05 pm | N/A 2033-02-01 | bluebird bio Inc. | BLUE | Vittiglio Joseph Chief Business & Legal Officer | 150,000 | $0 | 150,000 (Direct) | View |
2022-12-01 Option Award | 2022-12-05 4:49 pm | N/A 2032-12-01 | bluebird bio Inc. | BLUE | Krawtschuk Christopher Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |